Details for New Drug Application (NDA): 208100
✉ Email this page to a colleague
The generic ingredient in ERYTHROMYCIN is erythromycin stearate. There are one hundred and three drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the erythromycin stearate profile page.
Summary for 208100
Tradename: | ERYTHROMYCIN |
Applicant: | Pai Holdings Pharm |
Ingredient: | erythromycin |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Medical Subject Heading (MeSH) Categories for 208100
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION;TOPICAL | Strength | 2% | ||||
Approval Date: | Nov 20, 2017 | TE: | RLD: | No |
Complete Access Available with Subscription